Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 284 shares of common stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

  • On March 3, 2025, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 284 shares of the company's common stock.
  • The sale was executed at a price of $25.46 per share.
  • This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
  • The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
  • Following the transaction, Aebersold directly owns 59,907 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) under a pre-existing trading plan, so the sentiment is neutral.

Industry Context

Sales by company executives are a normal part of corporate governance. Often these sales are planned in advance using 10b5-1 trading plans to avoid any accusations of insider trading. It is common for executives to sell shares to cover tax obligations.

Stakeholder Impact

  • The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares sold and the pre-planned nature of the transaction.

Key Dates

DateDescription
02/24/2022Date of adoption of Rule 10b5-1(c) trading plan
03/03/2025Date of stock sale transaction
03/05/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.